Pediatric Pharmacotherapy Self Assessment
12%
off

Pediatric Pharmacotherapy Self Assessment

By (author)  , By (author)  , By (author) 

Free delivery worldwide

Available. Dispatched from the UK in 3 business days
When will my order arrive?

Description

A growing practice area, pediatric pharmacotherapy has been approved as a new board-certified specialty. Yet, with little clinical data on the efficacy of drugs used for children and their other special needs, these small patients can be your biggest challenge. Now there is a very effective way to assess and advance your pediatric pharmacotherapy skills, on your own time, at your own pace: ASHP's Pediatric Pharmacotherapy Self Assessment, created by Sandra Benavides, Hanna Phan, and Milap C. Nahata. Based on real-life situations, these cases present challenges in the use of supplements, OTCs, drug formulations, and all other therapies for neonates, children, and adolescents. Each case was designed to include patient-specific data for evaluation to formulate specific recommendations for all aspects of care. Pediatric Pharmacotherapy Self Assessment is a professional development tool for all areas of concern and levels of practice that can benefit you and your youngest patients for years to come.show more

Product details

  • Hardback | 300 pages
  • 215.9 x 274.32 x 17.78mm | 635.03g
  • American Society of Health-System Pharmacists
  • Bethesda, United States
  • English
  • 1585284246
  • 9781585284245

About Sandra Benavides

Sandra Benavides, PharmD, is an Associate Professor at Nova Southeastern University College of Pharmacy, Department of Pharmacy Practice. Dr. Benavides received her Doctor of Pharmacy from the University of California, San Francisco. She completed a general practice residency at the University of California, San Diego Medical Center and a Pediatric Pharmacotherapy Fellowship at The Ohio State University. Her clinical practice is in the area of pediatrics, and she has vast experience in a variety of pediatric settings including acute care, ambulatory, and community practice. Dr. Benavides has authored several peer-reviewed publications in the area of pediatrics and education. She is the lead editor for Pediatric Pharmacotherapy, the first pediatric pharmacy text written for students. She is also an author and editor for Get the Residency: ASHP's Guide to Residency Interviews and Preparation. Throughout her years as an academician and practitioner, Dr. Benavides has mentored many students on residency and career paths, particularly in the area of pediatrics. She offers a pediatric elective and an advanced pharmacy practice experience in ambulatory pediatrics and academia and is an enthusiastic proponent of providing students with learning opportunities to better serve the pediatric population.Hanna Phan, PharmDHanna Phan, PharmD, is an Assistant Professor in the Department of Pharmacy Practice and Science at the College of Pharmacy and in the Department of Pediatrics at the College of Medicine at the University of Arizona. She also serves as the Residency Program Director for the Post-Graduate Year 2 (PGY-2) Pediatric Pharmacy Residency at The University of Arizona Medical Center, Diamond Children s Center. Dr. Phan received her Doctor of Pharmacy (PharmD) from the University of Michigan and completed a Postdoctoral Fellowship in Pediatric Pharmacotherapy at The Ohio State University. As a Clinical Pharmacy Specialist in Pediatric Pulmonary Medicine, Dr. Phan provides care to her patients at University of Arizona Medical Center-Diamond Children s Center as well as its associated pediatric pulmonary specialty clinics. Dr. Phan is an advocate for pediatric pharmacy practice through her leadership and service in various professional pharmacy organizations, including the American Society of Health-System Pharmacists (ASHP), American College of Clinical Pharmacy (ACCP), Pediatric Pharmacy Advocacy Group (PPAG), and American Association of Colleges of Pharmacy (AACP). She has given various national presentations and authored numerous book chapters and peer-reviewed manuscripts in the area of pediatric pharmacotherapy. Dr. Phan was honored with the Pediatric Pharmacy Advocacy Group (PPAG) Spirit of PPAG Award and Arizona Pharmacists Association s Exemplary Patient Care Award in 2012. Her research efforts with her colleagues at The University of Michigan were honored with the American Society of Health-System Pharmacists (ASHP) Foundation Pharmacy Practice Research Award in 2009. Her current research interests include pediatric medication safety, patient-family education and therapy adherence, impact of body weight on medication use in children, and the role of pharmacists in the care of children with cystic fibrosis and asthma. Milap C. Nahata, PharmD, MS, is the Director of the Institute of Therapeutic Innovations and Outcomes; Professor Emeritus of Pharmacy at the College of Pharmacy; and Professor Emeritus of Pediatrics and Internal Medicine at the College of Medicine at the Ohio State University (OSU). He was Division Chair, Pharmacy Practice and Administration, College of Pharmacy and Associate Director, Medical Center Department of Pharmacy for nearly 15 years and Interim Director of the Latiolais Leadership Program at OSU for about 3 years. Nahata began his academic career in clinical pharmacy education, practice, research, and service at OSU in 1977. He teaches courses on pharmacotherapy and leadership, and has mentored nearly 200 graduate and professional students, residents and fellows. He has received seven outstanding teaching awards from the College of Pharmacy, a university teaching award from Ohio State, and two distinguished educator awards from national associations: American Association of Colleges of Pharmacy (AACP) and American College of Clinical Pharmacy (ACCP). He is a recipient of the Helms Award for Sustained and Significant Contributions to Advance Pediatric Pharmacy Practice from PPAG, co-recipient of the Best Practices Award from the American Society of Health-System Pharmacists (ASHP), and an elected Distinguished Practitioner in the National Academy of Practice for professional excellence and dedication to interdisciplinary care. With research focus in pediatric pharmacotherapy, Nahata has authored or coauthored over 500 peer reviewed journal articles, 70 book chapters, and four books (two authored and two edited) largely about the treatment of conditions affecting pediatric patients; majority of drugs are used off-label and have not been well studied in this population. Pediatric Drug Formulations is in sixth edition and is the most widely used book in this field, to provide access to information for preparing suitable formulations of drugs not commercially available for use in infants and young children. He is a recipient of five research achievement awards from national organizations: ACCP, ASHP, American Association of Pharmaceutical Scientists (AAPS), American Pharmacists Association (APhA), and Rho Chi Pharmacy Honor Society. He is a Fellow of ACCP, APhA, ASHP, American Academy of Microbiology, American College of Clinical Pharmacology, and American Association for the Advancement of Science (AAAS). He has presented over 300 invited lectures in Asia, Australia, Canada, Europe, New Zealand, and the US, including nearly 30 distinguished lectureships at various colleges of pharmacy. He is Editor-in-Chief of the Annals of Pharmacotherapy. Nahata is an elected member of the Institute of Medicine (IOM), National Academy of Sciences. He is a recipient of the Sumner Yaffe Lifetime Achievement Award in Pediatric Pharmacology and Therapeutics from PPAG, and the Paul Parker Medal for lifetime impact with outstanding and significant contributions for improving or expanding the profession of pharmacy from ACCP. He has served as President of both AACP and ACCP, and as chair or member of various national committees within pharmacy organizations, including AACP, ACCP, ACPE, AFPE, APhA, ASHP and Rho Chi Society, and of the National Institute of Child Health and Human Development (NIH), AHRQ, FDA, USP, IOM, Pew Health Professions Commission, National Academy of Practice, European Society of Clinical Pharmacy and International Pharmaceutical Federation. He served as a member of the Commission to Implement Change in Pharmaceutical Education, which led to PharmD as first professional pharmacy degree in US. He has been a member of two IOM committees leading to two influential reports (Emergency Care for Children and Safe and Effective Medicines for Children). He is a recipient of the Community Leadership Award from the Asian Indian Alliance. Former pharmacy students and fellows contributed to the establishment of the Milap Nahata Distinguished Lectureship at OSU College of Pharmacy in 2012. "show more